Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9GB6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,056
Award facts
- Contract value 100% obligated
- $12,055.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,055.84 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Renflexis 100 mg vials, with an ultimate completion date of December 17, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive pharmaceutical portfolio under its DLA prime contract encompasses brand-name and generic medications, vaccines, specialty treatments, and medical supplies across multiple therapeutic domains. This delivery order for Renflexis, a biologic immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, exemplifies the company's role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9GB6?
SPE2DR26F9GB6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F9GB6 worth?
The government has obligated $12,056 on SPE2DR26F9GB6.
Is contract SPE2DR26F9GB6 an order under another contract?
Yes. SPE2DR26F9GB6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GB6 competed?
The extent of competition for SPE2DR26F9GB6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award